Myo6^em1Bcgen

CRISPR/Cas9 technology generated a G to A change at position 1325 resulting in a cysteine to tyrosine substitution at residue 442 in exon 13. The C442Y missense variant is seen in patients with autosomal dominant nonsyndromic hearing loss. (J:288210)